abstract |
Compounds that inhibit the activity of Polycomb repressive complex 2 (PRC2) are disclosed. Specifically, compounds of formula (I) and pharmaceutical compositions thereof are disclosed, as well as methods of using the compounds and pharmaceutical compositions, eg, in methods of treating cancer. |